Drug Trial Radar · NCT04234048
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
46
Planned (sponsor's estimate)
Start
Dec 18, 2023
Primary completion
Jun 1, 2028
Study completion Nov 1, 2028
Sponsor
- Lead sponsor
- SciTech Development, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 21, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).
Conditions
- T-cell Lymphoma
- Cutaneous/Peripheral T-Cell Lymphoma
- Peripheral T-cell Lymphoma
- Peripheral T-Cell Lymphoma, Not Classified
- Primary Cutaneous T-cell Lymphoma
- Cutaneous T-Cell Lymphoma, Unspecified
- Cutaneous T-cell Lymphoma
- Follicular T-Cell Lymphoma
- Angioimmunoblastic T-cell Lymphoma
- Sézary's Disease
- Mycosis Fungoides
Interventions
FenretinideDrug
Accelerated Phase 1a 100% Dose escalation in 8 single-patient cohorts Standard Phase 1a 40% Dose escalation in 3-patient cohorts X 3 cohorts Phase 1b Dosed at MTD in 20 patients as disease-specific expanded cohort
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Tolerated Dose (MTD)Time frame: 12 months
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic Arizona
Scottsdale, Arizona · Recruiting
City of Hope Medical Foundation
Duarte, California · Recruiting
University of Southern California
Los Angeles, California · Recruiting
University of Colorado Anschutz Medical Campus
Aurora, Colorado · Recruiting
Northwestern University, Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois · Recruiting
University of Michigan
Ann Arbor, Michigan · Recruiting
Barbara Ann Karmanos Cancer Institute Wayne State University
Detroit, Michigan · Recruiting
Columbia University
New York, New York · Recruiting
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, Pennsylvania · Recruiting
The University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.